Celldex Therapeutics Inc (NASDAQ:CLDX)

28.87
Delayed Data
As of May 29
 -0.16 / -0.55%
Today’s Change
11.93
Today|||52-Week Range
32.82
+58.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues592.0K1.1M1.5M486.0K
 
 
 
 
 
Depreciation And Amortization836.0K857.0K877.0K925.0K
 
 
 
 
 
 
Operating ExpensesGross Income-244.0K244.0K600.0K--
 
 
 
 
General Expenses28.3M30.6M32.7M30.5M
 
 
 
 
 
Research And Development24.1M26.2M26.4M25.1M
 
 
 
 
 
Total Operating Expenses29.1M31.4M33.5M31.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.5M-30.3M-32.1M-31.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.3M-28.1M-31.8M-30.2M
 
 
 
 
 
Net Income-28.3M-28.1M-31.8M-30.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS89.4M89.4M89.6M92.4M
 
 
 
 
 
Shares To Calculate EPS Diluted89.4M89.4M89.6M92.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.32-$0.31-$0.36-$0.33
 
 
 
 
 
EPS Diluted-$0.32-$0.31-$0.36-$0.33
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account